首页 > 市场调查报告书 > 医疗设备

生技设备 3D列印

市场调查报告书

商品编码

1905526

日本3D生物列印市场报告（按组件（3D生物列印机、支架、生物材料）、应用（研究、临床）、最终用户（医院、研究机构和学术机构、生物製药公司）和地区划分，2026-2034）

Japan 3D Bioprinting Market Report by Component (3D Bioprinters, Scaffolds, Biomaterials), Application (Research, Clinical), End User (Hospitals, Research Organization and Academic Institutes, Biopharmaceuticals Companies), and Region 2026-2034

出版日期: 2026年01月01日 | 出版商:

IMARC | 英文 119 Pages | 商品交期: 5-7个工作天内

价格

简介目录

2025年，日本3D生物列印市场规模达9,630万美元。展望未来， IMARC Group预计到2034年，该市场规模将达到3.465亿美元，2026年至2034年间的复合年增长率（CAGR）为15.30%。老年人口对器官移植需求的不断增长，以及医疗技术的普及，是推动市场成长的主要因素。

本报告解答的关键问题：

日本3D生物列印市场目前表现如何？未来几年又将如何发展？
新冠疫情对日本3D生物列印市场产生了哪些影响？
日本3D生物列印市场按组件分類的组成是怎样的？
日本3D生物列印市场依应用领域分類的组成是怎样的？
日本3D生物列印市场依最终用户分類的组成是怎样的？
日本3D生物列印市场价值链的各个阶段有哪些？
日本3D生物列印的关键驱动因素与挑战是什么？
日本3D生物列印市场的结构是怎么样的？主要参与者有哪些？
日本3D生物列印市场的竞争程度如何？

Japan 3D bioprinting market size reached USD 96.3 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 346.5 Million by 2034, exhibiting a growth rate (CAGR) of 15.30% during 2026-2034. The elevating need for organ transplantation among the geriatric population, along with the easy access to medical technologies, is primarily driving the market growth.

Three-dimensional (3D) bioprinting is an additive manufacturing technique developed for the precise fabrication of anatomical tissues. This method encompasses various deposition and assembly processes, including direct and laser writing, microstamping, photolithography, stereolithography, electro-printing, and inkjet deposition. In addition to this, it relies on the layer-by-layer assembly of cell-based bio-inks, which are formulated using living cells, biomaterials, and active biomolecules, to construct 3D tissue and organ structures. By depositing multiple layers of biomaterials, 3D bioprinting can create complex bodily structures such as bones, skin, cartilage, vascular grafts, tracheal splints, and heart tissues. Consequently, it finds extensive applications in hospitals, research institutions, academic establishments, and biopharmaceutical companies across Japan.

Japan 3D Bioprinting Market Trends:

In the context of the Japan market, the increasing emphasis on reducing animal testing is a significant factor positively influencing the industry. Additionally, the rising demand for 3D bioprinting, particularly among the elderly population who are more susceptible to various chronic illnesses, is fostering a favorable market outlook, thereby acting as another significant growth-inducing factor. Besides this, technological advancements such as the development of organ-on-a-chip systems are also driving market growth. Furthermore, the surging global demand for regenerative medicines, cancer therapeutics, and stem cell solutions is contributing to the expansion of the market. Apart from this, the healthcare sector in Japan is increasingly adopting 3D bioprinting, and its relatively lower disruption level compared to other industries is providing substantial support to market growth. Moreover, prominent manufacturers are placing a strong focus on research and development (R&D) activities aimed at introducing bio printed tissues, which is positively influencing the regional market. This effort aims to reduce the cost associated with new innovations and streamline the drug discovery process, further propelling advancement within Japan. All these above mentioned factors are expected to catalyze the market growth over the forecasted period.

Japan 3D Bioprinting Market Segmentation:

Component Insights:

3D Bioprinters
- Syringe/Extrusion Bioprinting
- Inkjet Bioprinting
- Magnetic Levitation Bioprinting
- Laser-assisted Bioprinting
- Others
Scaffolds
Biomaterials
- Living Cells
- Hydrogels
- Extracellular Matrices
- Others

Application Insights:

Research
- Drug Research
- Regenerative Medicine
- 3D Cell Culture
Clinical
- Skin
- Bone and Cartilage
- Blood Vessels
- Others

End User Insights:

Hospitals
Research Organization and Academic Institutes
Biopharmaceuticals Companies

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan 3D bioprinting market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan 3D bioprinting market?
What is the breakup of the Japan 3D bioprinting market on the basis of component?
What is the breakup of the Japan 3D bioprinting market on the basis of application?
What is the breakup of the Japan 3D bioprinting market on the basis of end user?
What are the various stages in the value chain of the Japan 3D bioprinting market?
What are the key driving factors and challenges in the Japan 3D bioprinting?
What is the structure of the Japan 3D bioprinting market and who are the key players?
What is the degree of competition in the Japan 3D Bioprinting market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan 3D Bioprinting Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan 3D Bioprinting Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan 3D Bioprinting Market - Breakup by Component

6.1 3D Bioprinters
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Segmentation
  - 6.1.3.1 Syringe/Extrusion Bioprinting
  - 6.1.3.2 Inkjet Bioprinting
  - 6.1.3.3 Magnetic Levitation Bioprinting
  - 6.1.3.4 Laser-assisted Bioprinting
  - 6.1.3.5 Others
- 6.1.4 Market Forecast (2026-2034)
6.2 Scaffolds
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)
6.3 Biomaterials
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2020-2025)
- 6.3.3 Market Segmentation
  - 6.3.3.1 Living Cells
  - 6.3.3.2 Hydrogels
  - 6.3.3.3 Extracellular Matrices
  - 6.3.3.4 Others
- 6.3.4 Market Forecast (2026-2034)

7 Japan 3D Bioprinting Market - Breakup by Application

7.1 Research
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Segmentation
  - 7.1.3.1 Drug Research
  - 7.1.3.2 Regenerative Medicine
  - 7.1.3.3 3D Cell Culture
- 7.1.4 Market Forecast (2026-2034)
7.2 Clinical
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Segmentation
  - 7.2.3.1 Skin
  - 7.2.3.2 Bone and Cartilage
  - 7.2.3.3 Blood Vessels
  - 7.2.3.4 Others
- 7.2.4 Market Forecast (2026-2034)

8 Japan 3D Bioprinting Market - Breakup by End User

8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Forecast (2026-2034)
8.2 Research Organization and Academic Institutes
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Forecast (2026-2034)
8.3 Biopharmaceuticals Companies
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2020-2025)
- 8.3.3 Market Forecast (2026-2034)

9 Japan 3D Bioprinting Market - Breakup by Region

9.1 Kanto Region
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2020-2025)
- 9.1.3 Market Breakup by Component
- 9.1.4 Market Breakup by Application
- 9.1.5 Market Breakup by End User
- 9.1.6 Key Players
- 9.1.7 Market Forecast (2026-2034)
9.2 Kansai/Kinki Region
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2020-2025)
- 9.2.3 Market Breakup by Component
- 9.2.4 Market Breakup by Application
- 9.2.5 Market Breakup by End User
- 9.2.6 Key Players
- 9.2.7 Market Forecast (2026-2034)
9.3 Central/ Chubu Region
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2020-2025)
- 9.3.3 Market Breakup by Component
- 9.3.4 Market Breakup by Application
- 9.3.5 Market Breakup by End User
- 9.3.6 Key Players
- 9.3.7 Market Forecast (2026-2034)
9.4 Kyushu-Okinawa Region
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2020-2025)
- 9.4.3 Market Breakup by Component
- 9.4.4 Market Breakup by Application
- 9.4.5 Market Breakup by End User
- 9.4.6 Key Players
- 9.4.7 Market Forecast (2026-2034)
9.5 Tohoku Region
- 9.5.1 Overview
- 9.5.2 Historical and Current Market Trends (2020-2025)
- 9.5.3 Market Breakup by Component
- 9.5.4 Market Breakup by Application
- 9.5.5 Market Breakup by End User
- 9.5.6 Key Players
- 9.5.7 Market Forecast (2026-2034)
9.6 Chugoku Region
- 9.6.1 Overview
- 9.6.2 Historical and Current Market Trends (2020-2025)
- 9.6.3 Market Breakup by Component
- 9.6.4 Market Breakup by Application
- 9.6.5 Market Breakup by End User
- 9.6.6 Key Players
- 9.6.7 Market Forecast (2026-2034)
9.7 Hokkaido Region
- 9.7.1 Overview
- 9.7.2 Historical and Current Market Trends (2020-2025)
- 9.7.3 Market Breakup by Component
- 9.7.4 Market Breakup by Application
- 9.7.5 Market Breakup by End User
- 9.7.6 Key Players
- 9.7.7 Market Forecast (2026-2034)
9.8 Shikoku Region
- 9.8.1 Overview
- 9.8.2 Historical and Current Market Trends (2020-2025)
- 9.8.3 Market Breakup by Component
- 9.8.4 Market Breakup by Application
- 9.8.5 Market Breakup by End User
- 9.8.6 Key Players
- 9.8.7 Market Forecast (2026-2034)

10 Japan 3D Bioprinting Market - Competitive Landscape

10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant

11 Profiles of Key Players

11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Services Offered
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Services Offered
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Services Offered
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Services Offered
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Services Offered
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events

12 Japan 3D Bioprinting Market - Industry Analysis

12.1 Drivers, Restraints, and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
12.3 Value Chain Analysis

13 Appendix

02-2729-4219

+886-2-2729-4219

License/价格

日本3D生物列印市场报告（按组件（3D生物列印机、支架、生物材料）、应用（研究、临床）、最终用户（医院、研究机构和学术机构、生物製药公司）和地区划分，2026-2034）

Japan 3D Bioprinting Market Report by Component (3D Bioprinters, Scaffolds, Biomaterials), Application (Research, Clinical), End User (Hospitals, Research Organization and Academic Institutes, Biopharmaceuticals Companies), and Region 2026-2034

本报告解答的关键问题：

目录

第一章：序言

第二章：范围与方法

第三章：执行概要

第四章：日本3D生物列印市场－简介

第五章：日本3D生物列印市场概况

第六章：日本3D生物列印市场－按组件细分

第七章：日本3D生物列印市场－依应用领域划分

第八章：日本3D生物列印市场－依最终用户划分

第九章：日本3D生物列印市场－按地区划分

第十章：日本3D生物列印市场－竞争格局

第十一章：关键参与者简介

第十二章：日本3D生物列印市场－产业分析

第十三章：附录